Literature DB >> 9096983

Health insurance and the financial impact of IDDM in families with a child with IDDM.

T J Songer1, R LaPorte, J R Lave, J S Dorman, D J Becker.   

Abstract

OBJECTIVE: To examine the health insurance experience and out-of-pocket health care costs of families with a child with IDDM. RESEARCH DESIGN AND METHODS: A case-control study of 197 families with a child with IDDM and 142 control families with no diabetic children was conducted. IDDM-affected families were identified from the Allegheny County IDDM Registry. Brothers and sisters of the parents in the IDDM-affected families were asked to participate as control subjects. Health insurance coverage and the money that families spent on health care services and supplies not reimbursed by insurance (out-of-pocket costs) were assessed by questionnaire.
RESULTS: No difference was found between the IDDM-affected and control families in the percentages with or without insurance. Families with low household incomes ($10,000-$19,999) were at the greatest risk for having no insurance. While coverage provided by private plans was similar between the IDDM-affected and control families, many families had no reimbursement for insulin (10%), syringes (10%), or blood testing strips (30%). Out-of-pocket expenses were 56% higher in the IDDM-affected families than in the control families. Seventeen percent of the IDDM-affected families had expenses over 10% of their household income. This particularly affected families with low household incomes. Pre-existing illness clauses and insurance denial affected only a small proportion of the case families.
CONCLUSIONS: These data illustrate that most families with a child with IDDM have health insurance, yet still incur larger out-of-pocket health care costs than do families without the presence of diabetes. IDDM-affected families likely face a number of economic decisions regarding health insurance and the use of health care.

Entities:  

Mesh:

Year:  1997        PMID: 9096983     DOI: 10.2337/diacare.20.4.577

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Impact of type 1 diabetes mellitus on the family is reduced with the medical home, care coordination, and family-centered care.

Authors:  Michelle L Katz; Lori M Laffel; James M Perrin; Karen Kuhlthau
Journal:  J Pediatr       Date:  2011-12-01       Impact factor: 4.406

2.  Effect of cost-sharing changes on self-monitoring of blood glucose.

Authors:  Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; James Chan; Michele M Spence; Joe V Selby; Susan L Ettner
Journal:  Am J Manag Care       Date:  2007-07       Impact factor: 2.229

3.  Characteristics of children with type 1 diabetes and persistent suboptimal glycemic control.

Authors:  Hyuntae Kim; Angelo Elmi; Celia L Henderson; Fran R Cogen; Paul B Kaplowitz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

4.  Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization Questionnaire.

Authors:  Arlene Smaldone; Argerie Tsimicalis; Patricia W Stone
Journal:  Res Theory Nurs Pract       Date:  2011       Impact factor: 0.745

5.  How Much Time Do Families Spend on the Health Care of Children with Diabetes?

Authors:  Jane E Miller; Colleen N Nugent; Louise B Russell
Journal:  Diabetes Ther       Date:  2016-06-27       Impact factor: 2.945

6.  Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Authors:  Taylor M Triolo; H Peter Chase; Jennifer M Barker
Journal:  Diabetes Care       Date:  2009-05       Impact factor: 17.152

7.  Health care access and glycemic control in youth and young adults with type 1 and type 2 diabetes in South Carolina.

Authors:  Angela D Liese; Xiaonan Ma; Lauren Reid; Melanie W Sutherland; Bethany A Bell; Jan M Eberth; Janice C Probst; Christine B Turley; Elizabeth J Mayer-Davis
Journal:  Pediatr Diabetes       Date:  2019-02-19       Impact factor: 3.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.